glp-1 obesity drug news october 21 2025 New Pill Foundayo (Orforglipron) Gets FDA Approval for With FDA approval of Wegovy

2021;143:e9841010

PLoS One 12 (5), e0177545

Comparison with other studies Overall, events of suicidal ideation and self-harm have not been found to be imbalanced in clinical trials between randomised groups.67 However, these trials were limited by their sample sizes and thus could not detect these rare but potentially important adverse events

As the global anti-obesity drug market continues to expand, injectable therapies are poised to remain at the forefront of treatment options, offering effective solutions for weight management and related health conditions

The statements and products listed on this website are not intended to diagnose, treat, cure, or prevent any disease.

But it takes thoughtful consideration of how or if you will offer coverage, what tools youll have in place to help ensure your drug spend aligns with your coverage strategy, and effective ways you can empower your members to learn and put in practice the necessary lifestyle changes that are critical to achieving and sustaining better outcomes